Previous 10 | Next 10 |
home / stock / acxp / acxp articles
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its national business TV show airing...
Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expected sales for ...
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) -- FMW Media Work announces that its "New to The Street Leadership," Powered by Sector SPDR ETF...
NEW YORK, Feb. 02, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street is airing its national TV show on the FOX Business Network on Mond...
NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street TV announces the broadcasting of its business show airing on Bloom...
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a national TV show, announces episode 551, airing on the FOX Bu...
NEW YORK, Jan. 19, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television producti...
Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announced a partners...
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally broadcasted TV show, announces episode 543, airing o...
News, Short Squeeze, Breakout and More Instantly...
Acurx Pharmaceuticals Inc. Company Name:
ACXP Stock Symbol:
NASDAQ Market:
Acurx Pharmaceuticals Inc. Website:
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street announces the broadcasting of its national business TV show airing on Bloomberg TV as sponsored programming tonight, Thursday, June 6, 2024, at 9:30 PM PT. New to The Street's TV episode 576 will air the follo...
Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection PR Newswire Agreement with FDA reached on key elements to move forward with our international Phase 3 clinical trial program Agreement al...
Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , May 15, 2024 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a clinical stage biophar...